C]Rac1opride binding to central D2dopamine receptors in humans has previously been ex amined by positron emission tomography (PET) . Based on the rapid occurrence of binding equilibrium, a satura tion analysis has been developed for the determination of receptor density (BmaJ and affinity (Kd). For analysis of PET measurements obtained with other ligands, a kinetic three-compartment model has been used. In the present study, the brain uptake of [lICJraclopride was analyzed further by applying both a kinetic and an equilibrium anal ysis to data obtained from four PET experiments in each of three healthy subjects. First regional CBV was deter mined. In the second and third experiment, e 'CJ raclopride with high and low specific activity was used. In a fourth experiment, the ["CJraclopride enantiomer [1IC]FLB472 was used to examine the concentration of Positron emission tomography (PET) allows the analysis of radioligand binding to receptors in the human brain in vivo (Wagner et aI. , 1983; Sedvall et aI. , 1986). The usefulness of a radio ligand for PET studies is determined by binding characteristics such as high selectivity and high affinity for the re ceptor population of interest and a low nonspecific binding. Taking account of the individual character istics of ligands hitherto developed, suitable quan-
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titative approaches have been applied to interpret the regional uptake curves in terms of parameters such as receptor density (Bmax) and affinity (Kd) .
For ligands with a slow dissociation rate from the receptor, such as spiperone and its derivatives, a kinetic analysis according to a compartment model has provided valuable information (Mintun et aI. , 1984; Wong et aI., 1986a; Logan et al. , 1987; Huang et aI. , 1986) . The highly selective D2-dopamine re ceptor antagonist [ ll C]raclopride, by contrast, dis sociates rapidly from the receptors, allowing equi librium of binding to be established in vivo within the time span of a PET experiment (Kohler et aI. , 1985; Farde et aI. , 1985) . By systematically varying the specific activity in a previous series of PET ex periments in the same individual, an equilibrium analysis of central [ ll C]raclopride binding has been performed (Farde et aI. , 1986) . Regional time activity curves were used to define a point in time that represents equilibrium of specific binding to D2-dopamine receptors . On the basis of regional ra dioactivity at that moment, Bmax and Kd values were calculated from saturation curves and Scatch ard plots.
A kinetic analysis of rt lC]N-methylspiperone ([l1C]NMSP) uptake in the striatum before and after administration of haloperidol has been developed for the study of D2-dopamine receptor densities in healthy controls and neuroleptic-naive patients with schizophrenia (Wong et al ., 1986b) . A two-to three fo ld elevation in densities was reported in the pa tients. No elevation was found by another PET cen ter when applying an equilibrium analysis with [l1C]raclopride in 18 neuroleptic-naive schizophren ics and 20 healthy controls . Ex perimental and modeling differences between the kinetic approach with e lC]NMSP and the equilib rium approach with e lC]raclopride have been dis cussed as a reason for these highly discrepant find ings (Andreasen et al., 1988) .
The equilibrium dissociation constant (Kd) is the ratio of the dissociation rate constant (koff) to the association rate constant (kon)' A kinetic analysis of the time-activity curves fo r the rapidly dissociating ligand e lC]raclopride may allow determination of those two rate constants in vivo. Such analysis gives more detailed information about receptor binding characteristics in vivo that should be of value fo r receptor studies in patients with neuropsy chiatric disorders and for the pharmacological char acterization of drugs.
Both when applying an equilibrium and a kinetic analysis, a key problem is to separate the measured radioactivity corresponding to specifically bound radioligand from that corresponding to free and nonspecifically bound radioligand . In vitro, the free and nonspecific binding can be examined quantita tively after blockade of all specific binding sites by either an excess of unlabeled ligand or an unlabeled displacing substance that saturates all specific bind ing sites. Such approach cannot be performed when examining D2-dopamine receptors in humans in vivo because of the side effects that are related to phar macological doses of D2-dopamine receptor ago nists or antagonists. An alternative for the exami nation of free and nonspecific binding is to use [1lC]FLB472, the inactive enantiomer of [llC] _ raclopride . Enantiomers have identical physicochemical properties, such as li pophilicity, but are markedly diffe rent with regard to specific binding (Craig, 1976) . They may also be different with regard to protein binding in plasma and to metabolism (Giacomini et al., 1985; Olanoff et al., 1984; Thijssen et al., 1985) .
The main aim of the present study was to exam-ine [llC]raclopride and [1lC]FLB472 uptake in brain by a kinetic compartmental analysis. For a compar ison to the previously developed equilibrium proce dure, a Scatchard analysis was made using the same experimental data. Particular emphasis was placed on evaluating if the three-compartment model rep re sents an adequate description of the brain uptake of [IlC]raclopride in humans .
METHODS

Experimental procedure
The study was approved by the Ethics and Isotope Committee of the Karolinska Hospital. Three healthy vol unteers, age 22, 25, and 34 years, were selected for the study. They were healthy according to history, clinical examination, and blood and urine chemistry.
Each subject underwent four PET experiments. In each experiment, 200-250 MBq (5.4-6.7 mCi) were injected. In the first experiment, regional cerebral blood volume (rCBV) was measured using CO-hemoglobin. In the sec ond and third experiment, [llC]raclopride with a high SA (range of 810-1,060 Ci/mmol) and a low SA (range of 2.4-3. 1 Ci/mmol) was injected, respectively. In the fourth experiment, the inactive enantiomer P 'C]FLB472 with a high SA was injected (range of 563-1, 180 Cilmmol).
General values for regional cerebral blood flow (rCBF) are found in the literature. To obtain rCBF values in ex actly the regions defined and drawn in the present study, an additional experiment was performed in subject C. The subject inhaled 800 MBq (25 mCi) of CH3F. The details of the experimental procedure and calculations are pub lished elsewhere (Roland et al., 1987) . The first-pass ex traction of [llC]raclopride was calculated using the ex pression k, = CBF x E, where E is the first pass extrac tion fraction (Gjedde, 1982) .
[llC]CO-hemoglobin was synthesized by trapping CO in a 10 ml suspension of sterile saline and red blood cells of the volunteers (Nilsson et al., 1985) .
[llC]Raclopride and ["C]FLB472 were synthesized by alkylation of the corresponding desmethyl compound . After the synthesis, [llC]raclopride and [llC]FLB472 were purified with HPLC. To vary the specific activity (SA), a sterile solution of raclopride tartrate was added. The amount that was added was calculated on the basis of the desired SA, the radioactivity predicted at the time for injection, and the concentration of the raclopride tartrate solution. Before the PET experiment, a separate analyt ical HPLC system was used to measure the radiochemical purity of [llC]raclopride or [llC]FLB472. After radioli gand injection, the total chemical mass was determined for the calculation of the SA actually injected.
Radioactivity was measured with the Scanditronix pos itron camera PC384-7B (Litton et al., 1984) . In the exper iments with [llC]CO-hemoglobin, PET measurements started 6 min after injection of ["C]CO-hemoglobin and lasted for 20 min in a series of 2 min scans. In the radio ligand experiments, the first nine measurements lasted 20 s each, the next four lasted 3 min, and the remaining scans 6 min up to the end of the experiment after about 69 min. A head fixation system with an individual plaster hel met was used both in computerized tomography (CT) and PET to standardize the positioning of the brain 198 1) . In each subject, the foramen of Mon ro was identified with CT and the brain positioned so that the middle of PET section number four was 3 mm above the foramen. The head fixation system allows repeated PET experiments on the same individual with the same positioning of the head. The error for the reproducibility of positioning between experiments is less than 2 mm in all directions (Bergstrom et al., 198 1) .
A venous cannula was inserted into the right antecu bital vein. Radioactivity was administered as a rapid in travenous injection «2 s) into the right cubital vein. The cannula was then immediately flushed with 10 ml of sa line. Regions of interest (ROIs) were drawn on the CT images. After reconstruction of the sequential PET im ages, ROls were transferred to the PET images. By in spection of the image circumference, the ROls could be moved to adjust for the previously mentioned up to 2 mm error of positioning in the plane. Curves were generated for regional radioactivity as a function of time.
In the experiment with CO-hemoglobin, venous sam ples were drawn from the left antecubital vein 5, 10, 15, and 20 min after injection. In the radio ligand experiments, a cannula was inserted into the left brachial artery. Dur ing the first 5 min, an automatic blood sampling system (ABSS) was used .
The ABSS consists of a long catheter, a detector to measure the concentration of radioactivity in the cathe ter, and a peristaltic pump to draw arterial blood into the catheter. The pump speed was set to 5 mIlmin. The de tector system was connected to a microprocessor, and the concentration of radioactivity in the catheter was measured and stored every second. Measurements of ra dioactivity in blood, as well as measurement with the positron camera, started immediately before the injec tion. From the open end of the catheter, four blood sam ples (1.25 ml, sampling time of 15 s) were taken 1, 2, 3, and 4 min after injection. These samples were used for calibration of the ABSS and for the determination of plasma conversion factors used to calculate the curve for radioactivity in plasma, C p (t). Data from the ABSS and the total count rate from the positron camera were trans ferred to the dedicated VAX ]]/780 computer and infor mation was obtained about the time shift between the arterial blood curve and the total brain uptake curve that was measured with PET.
To avoid drawing too much blood from the volunteers (5 mIlmin), the ABSS was used only during the first 5 min. Thereafter, arterial blood samples (2 ml) were drawn manually at each scan until the end of the experiment. One milliliter of the manually drawn samples was imme diately pipetted and measured for ] 0 s in a well counter. After centrifugation, 0.2 ml plasma was pipetted and plasma radioactivity was also measured in the well counter. The delay between the whole blood and plasma counting was 3-5 min. After correction for decay, the ratio of the radioactivity in whole blood to plasma equalled the hematocrit.
The blood and plasma values from the manual samples were fitted to a sum of three exponential functions. The fitted curves provided interpolated values for each sec ond, i.e., the same time scale as the data from the ABSS. Numerical blood curves were used since the model cal culations were made numerically. The calibrated curve from the ABSS and the fitted curve from the manual sam ples were displayed in the same graph. The best fit be tween the two curves was obtained by shifting the manual J Cereb Blood Flow Metab, Vol. 9, No.5, 1989 curve in time ( Fig. 1 ). When the best visual fit was estab lished, a point in time was chosen close to the beginning of the overlap region. The resulting blood curve was based on the ABSS before this point in time and on the manual samples after this point.
The radioactivity concentration in blood changes rap idly during the first minutes after radio ligand injection (Fig. 1) . The peak has a duration of about 20 s with a full-width at half-maximum of less than 8 s. Manual sam pling techniques are too slow to catch the peak accu rately. The use of a ] m long catheter in the present ABSS, however, introduces dispersion of the measured curve. To measure the sensitivity and dispersion, [68Ga] was injected into the system. The step response at a pump speed of 5 mIlmin was fitted to the function A x {Iexp[ -(t -to)/I1}, where T is the time constant, to the start time, and A is the product between the activity con centration and the sensitivity. The dispersion is defined as the time derivative of the step response to the function above. The time constant of the step response function was 2 s and the sensitivity was 200 cps//LCi/ml. The influ ence of dispersion of the blood curve was examined by numerically deconvoluting the dispersion from the arte rial blood curve obtained with the ABSS. When correct ing for dispersion, the kl' k2' and Bmax values became 8-9% lower. The values for kon and koff became 8-9% higher. The reduction in kl and k2 values when correcting for dispersion are in accordance with a previously re ported finding for CH3F measurements of CBF .
For the determination of plasma protein binding, a ] 0 ml blood sample was drawn in connection with the PET experiments. The plasma was frozen and the protein binding of FLB472 and [llC]raclopride was later deter mined by ultrafiltration .
In each experiment the fraction of the radioactivity in plasma representing unchanged [llC]raciopride or [IIC]FLB472 was determined by thin layer chromatogra phy (TLC). A silical gel plate was developed with a mix ture of ethyl acetate-methanol-water (80: 15: 5 vlvlv), dried, and inspected in ultraviolet light (254 nm). The dif ferent spots were scraped from the plate, collected in plastic tubes, and radioactivity was measured in a well counter for quantitation. The fraction of unchanged ligand was determined 4 and 42 min after injection. To correct C p (t), the plasma radioactivity curve, for metab olites, an exponential function was fitted to the measured values for changed ligand at 4 and 42 min after injection and to the assumed value of 0% at 0 min. Unchanged raclopride in plasma has in rrevious PET experiments been determined both with HPLC and TLC. In three healthy subjects, 12 samples were drawn from 1 to 48 min after injection of [IlC]raclopride with low SA Farde et ai., 1989b) . A monoexponential function gave a good fit to the 12 values for changed ligand. The HPLC values were in good agreement with those ob tained with TLC.
Theory
The PET system measures the regional concentration of radioactivity in brain as a function of time. Additional information is provided by measurements of radioactivity and ligand metabolism in arterial blood and plasma during a PET experiment. To quantify receptor binding, the time curves for regional radioactivity are interpreted in terms of receptor models.
The PET system measures both the radioactivity in brain tissue and in cerebral blood vessels. This condition can be formulated as (1) where Cpet(t) is the measured radioactivity concentration (nCilml) at time t. The terms C�!'s T(t) and Ccbv(t) are the concentrations in brain tissue and in the cerebral blood vessels (dimensions: nCi/ml). Regional cerebral blood volume (rCBV) can be determined in a separate experi ment and used to calculate Ccbv(t) in the ROIs. The sum of CIt) and Cb(t), when predicted from a model, gives Cir;;JD EL(t).
The compartment model applied for kinetic analysis of radioligand binding has been developed as an extension of the Sokoloff model for deoxyglucose (Sokoloff et ai. , 1977; Phelps et ai., 1979; Mintun et ai., 1984; Wong et ai., 1986a; Huang et ai. , 1986) . Three compartments are de fined (Fig. 2) : the radioactivity concentration of radioli gand in plasma (Cp), the radioactivity concentration of free radioligand in brain (Cr), and that of radioligand spe cifically bound to receptors (Cb). All concentrations have the dimension of nCi/mi. It is assumed that all compart ments are homogeneous in concentration.
The model predicts the following differential equations:
k" k2, k3, and k4 are first order rate constants with the dimension of (1/min). The rate constant k3 is the product
The three-compartment model used to interpret re gional brain radioactivity after Lv. injection of a radioligand. Cb and Cr as functions of Cp and the four rate constants (Phelps et ai., 1979) .
The information from one experiment with high SA al lows determinations of the product konBmax, referred to as the "binding potential" by Mintun et ai. (1984) . To calculate separately Bmax and kon' additional information is required from experiments with low specific activity, i. e. , a high total dose of injected radioligand. In such experiments, the nonlinear factor Cb/SA is important and on the same order as Bmax, i.e. , radioligand binding ap proaches saturation of the receptor population. As ob served by Blomquist et ai. (1988) , Cr can be obtained from an analytical expression obtained by summing Eqs. (2) and (3) and replacing d(C[ + Cb)ldt with dC�!'s T(t)ldt:
If CIt) is known, Cb(t) can be solved in terms of Cit):
Biochemical strategies for the determination of recep tor characteristics in vitro are based on Michaelis Menten's model for enzyme kinetics as applied to ligand receptor interaction (Michaelis and Menten, 19 13; Clark, 1937; Scatchard, 1949) . Binding is measured at equilib rium after incubation in vitro with systematically varied concentrations of radioligand. Bmax and Kd values are then obtained from a saturation hyperbola or a Scatchard plot. A similar procedure has also been applied for the in vivo PET analysis of specific [1'C]raclopride binding with PET (Farde et ai. , 1986) . A secular equilibrium was de fined as established in vivo when the ratio of specific binding to free radioligand concentration does not change further with time. At least two experiments with widely different specific activities are required to obtain Bmax and Kd values by means of such analysis.
Specific ["C]raclopride binding Cb(t) reaches a peak within the time span of a PET experiment. The derivative for specific binding (dCbldt) is at that moment 0 ( Fig. 3) . Theoretically, the conditions for a "true" equilibrium are fulfilled at that moment, since the same number of mol ecules dissociate from the Dz-dopamine receptors as those that associate to them.
When dCbldt is 0, the formulas for the saturation curve and Scatchard plot can easily be derived from one of the differential equations describing the kinetic model, i.e., when dCbldt is 0, Eq . (4) can be simplified to (7) The ratio korrlkon is Kd, the equilibrium dissociation con stant with the dimension nM. B is the density of radioli gand bound to receptors and has the dimension pmol/ml: B = CJSA. Replacement with Kd, division of both sides by SA, and rearrangement of terms gives the equation for the saturation hyperbola
where F is the concentration of free radioligand and has the dimension nM (or pmol/ml): F = CrlSA. After rear rangement of terms, the equation for the Scatchard curve is given:
A saturation analysis based on a definition of equilibrium, as occurring in vivo when dCbldt is 0, thus represents a special case of the three-compartment analysis defined by Eqs.
(2) and (4) . A saturation analysis can only be applied in vivo if specific binding reaches a peak within the time span of a PET experiment .
In regions with no specific binding sites, Cb is O. In such regions, the three-compartment model may be sim plified to a two-compartment model with the compart ments Cp and C��s T. The radioactivity in tissue is de scribed by the model equation C MODEL (t) = k x e-k2t (f C (u) e-k2U du (10)
IIss 1 Jo P which is a generalization of the flow equation originating from Kety (1951) . kl and kz are the rate constants for the influx and efflux across the blood-brain barrier. By com paring C��DEL(t) with C��s T(t) in a least-square sense, the rate constants kl and kz are determined .
Calculations and determination of receptor characteristics
Since the PET system measures radioactivity in a num ber of scans (time frames), Eq . (I) must be integrated during the time of each scan . By denoting the start and stop of scan number i with T; and T; + 1 in an experiment with sequential scans, Eq.
(1) can be rewritten as
The contribution from radioactivity in blood Ccbv(t) can be expressed as rCBY x Ca(t), where Ca(t) is the time activity curve for arterial blood and rCBY is the blood volume fraction. rCBY was determined from the separate experiment with CO-hemoglobin (Kuhl et al., 1975; Phelps et aI ., 1979) . Ccbv(t) was subtracted from Cpe,(t) to give C��s T(t), integrated from T; to T; + 1.
Fit of the three-compartment model to experimental data
The conventional strategy in kinetic PET modeling is to estimate parameters by fitting a model in a least-squares sense to the measured regional time-activity curve for all the is obtained in a PET experiment.
In all experiments with a high SA of [I I Clraclopride and [IIC]FLB472, the three-compartment model, described by Eqs. (2) and (3) and with k3 as a constant, was fitted to the time-activity curves for the putamen. This analysis provided a first visual impression of the model's potential for describing regional uptake and binding of [IIC] _ raclopride. As shown in Fig . 4A -C, the fit was excellent and was in the following analysis used to give interpola tion values on a second by second basis for C��s T(t). The fitting procedure also provided information useful for set ting the constraints on k1, k2, and k4 (see below) . To ob tain a fitted curve and hence interpolation values for C��s T(t) in the experiments with low SA, k3 was set as a constant also in these experiments. An example of the fits is given in Fig. 4D . The fitted time-activity curve C��s T(t) was used to obtain the values for dC��s T(t)ldt used for calculating Ct<t) according to Eq. (5) .
Quantitative approaches
For the calculations of Bmax, kon, and koff, the original differential equations (2) and (4) were used. For each ex periment with [llC]raclopride or [llC]FLB472, radioac tivity was measured in 19-22 sequential scans, covering 57-69 min. Together, the two experiments with [IIC]raclopride provided about 40 equations for an itera tive least-squares fit . For each experiment} and for each scan i, a function was formed. The overall strategy ap plied in this paper was to use Eq. (4) 
The sum of these functions squared Q is given by the expression j�nSA;i�nT
The function Q was minimized with a least-squares tech nique. The minimization procedure was based on the pro gram Minuit (James et aI., 1975) implemented on a VAXll-780. nSA is the number of experiments with dif ferent SAs and nT is the number of scans in each exper iment.
The quantitative procedure according to Eq. (13) re quires that CIt) is known. In the present paper, the three approaches presented below (a�) were used to obtain an estimate of Cit).
(a) Quantitative approach with reference region
Cerebellum is a brain structure with a negligible density of Dz-dopamine receptors (Kuhar et al., 1978; Martres et aL, 1985) . For the equilibrium analysis and also in several kinetic approaches, the total radioactivity in the cerebel lum has been used as an estimate of the free radioligand concentration in the striatum (Maziere et aI., 1985; Farde et aL, 1986; Eckemas et aL, 1987) . In this approach, when comparing the kinetic analysis to the equilibrium proce dure, the total radioactivity in the cerebellum, corrected for blood volume, was used as an estimate for CIt). The plasma radioactivity curves were accordingly not used as input functions in this approach.
(b) Quantitative approach with enantiomer
Enantiomers have identical physicochemical character istics but are different with regard to specific binding (Craig, 1976 ( c) Quantitative approach with five parameters By simultaneously operating Eqs. (5) and (10) in the least-squares minimization procedure, values for kl and kz were obtained in addition to Bmax, kon, and koff' To avoid local minima, limits were imposed on k1, kz, and k4.
The choice of limits was guided by the values obtained in the analysis described above, where the three compartment model was fitted to experimental data. In all three subjects, the limits were 0.15 < k l < 0.20, 0.30 < kz < 0.45, 0.07 < k4 < 0.15. The program starts with given values for kl and kz, with the plasma curve C/t) and the dCtis .ldt, and calculates the concentration of free ligand according to Eq. (5). The program then looks up the start values for kon, koff, and Bmax and gives a function Q ac cording to Eq. (13). In the following iterations, the pro gram takes new kl and kz values and repeats the proce dure to find a minimum.
To investigate the error propagation in the minimiza tion program functions, fj were simulated. They were based on the two [llC]raclopride experiments in subject C, with the following five parameters: kl = 0.17, kz = 0.42, Bmax = 22, kon = 0.014, and koff = 0.10. Ten sets of time-activity curves and hence functions fj were gener ated according to a normal distribution, with a 10% stan dard deviation in each radioactivity value. Ten percent was considered to be the maximal error in each value. Equation (13) was then used to find the best solution for each of the 10 data sets in a least-squares sense. The mean values and the standard deviations for the five dif ferent parameters were kl = 0.171 ± 0.01, kz = 0.43 ± 0.04, Bmax = 22 ± 4, kon = 0.015 ± 0.003, and koff = 0.11 ± 0.02. k] seems to be quite insensitive to error in the activity data. The 10% error in raw data implies a 10% error in kz, and around 20% errors in the remaining three parameters, Bmax, kon, and koff'
Scatchard analysis
The total radioligand concentration in the cerebellum was used as an estimate of F, the free radioligand con centration in the putamen. Specific binding (B) was de fined as radioactivity in the putamen reduced with F. For each SA, the curve for B was fitted to a set of three exponential functions and the program determined the point in time when dCbldt was O. The values for B and F at that point in time were used in a Scatchard analysis where the ratios BIF were plotted vs. F (Scatchard, 1949) .
Examination of the compartment Cf
To examine which of the two-compartment and the three-compartment model was best suited to describe ex perimental data in a region with a negligible density of Dz-dopamine receptors, both models were fitted to the measured radioactivity concentration in the cerebellum following [llC]raclopride injection. The models were also fitted to measures in the putamen and cerebellum after injection of [llC]FLB472, the enantiomer with no specific binding to Dz-dopamine receptors.
As remarked by Hawkins et aL (1986) , the model with the lowest residual sum of squares (RSS) is not necessar-ily the most adequate in describing experimental data. For the comparison of the two models, the statistical methods recommended by Landaw and DiStefano (1984) have been adopted. The methods are F statistic (Hawkins et al., 1986) , the Akaike information criterion (AIC) (Akaike, 1974) , and the Schwarz criterion (SC) (Schwarz, 1978) . AIC is defined by AIC = N In(RSS) + 2P, where N is the number of scans and P is the number of param eters. SC is defined by SC = N In(RSS) + P In(N). AIC and SC both generate a number, which should be as low as possible. If all three methods give preference to a cer tain model, this preference is considered to be significant (Landaw and DiStefano, 1984) .
RESULTS
The individual CBV fractions were 3.2, 2.7, and 2.6% in the putamen. In the cerebellum, the values were 5.4, 4.6, and 3.6%. The protein binding in plasma was 93.7, 95 .2, and 94.8% fo r [IIC] _ raclopride and it was 92.6, 93. 1, and 92.2% for [ llC ] _ FLB472. The fractions of unchanged [ l lC] _ raclopride in plasma are presented in Table 1 . The CBF for subject C was 60 mll1 00 g/min in the whole brain, 95 mIll 00 g/min in the region drawn for the putamen, and 55 ml/1 00 g/min in the region for the cerebellum. The kJ values in this subject were 0. 18 in the whole brain, 0. 18 in the putamen (Table  2) , and 0. 11 in the cerebellum (Table 3) . Those val ues were used to calculate a first-pass extraction of 30% in the whole brain, 20% in the putamen, and 20% in the cerebellum.
Fit of the three-compartment model
After intravenous bolus injection of the radioli gands, the automatic blood sampling system (ABSS) measured a high and transient peak in ar terial blood radioactivity (Fig. 1) . When the three compartment model was fitted to experimental data measured in the putamen after injection of e lC]raclopride with high SA, it gave a good fit ( Fig.   4A-C) . To obtain interpolated values on a second by second basis for the uptake curves in the puta men, the compartment model was also fitted to the measures obtained after injection of [ llC ]raclopride with low SA. The time dependency of the rate con stant k3 was neglected but the fits were very good nevertheless, as exemplified in Fig. 4D . The kJ and k2 values were in agreement with those obtained in the experiment with a high SA ( Table 2) .
The kJ and k2 values used in Eq. (5) to calculate the curve for Ct<t) predicted by the model were in all subjects uniform at a similar level as the measured [IIC]raclopride concentration in the cerebellum ( Fig. 4A-C) . The curves Ct<t), calculated from the rate constants obtained in experiments with e JC]raclopride and a low SA, were also on the same level as the radio ligand concentration in the cere bellum (example given in Fig. 4D ) .
Quantitative approach with reference region
When the total radioligand concentration in the cerebellum was used as an estimate of Ct<t), the kinetic analysis according to Eq. (13) gave Bmax val ues of about 30 pmollml and Kd values of about 10 nM (Table 3) . The contribution to the sum of squares according to Eq. (13) was much larger from the equations representing the experiment with a low SA than with a high SA. High squares were in particular obtained from equations during the first 3 min after injection of e JC]raclopride with low SA.
These equations from the first 3 min resulted in 10--20% lower Bmax values than if they were ne glected. Quantitative approach with five parameters kJ and k2 values were determined in addition to Bmax, kon' and koff' The minimization program found a minimum and did not converge to the limits for the k values. The kJ values were 0. 17, 0. 19, and 0. 16 The three kinetic approaches (a--c) are described in the Methods section. n.a. = not applicable. Dimensions: Bmax (pmol/ml), Kd (nM), kon (l/min/nM) , koff (l/min). and the k2 values 0.42, 0.36, and 0.30. Slightly lower gave separate values for kon and k O ff' Those values Bmax values were found in all subjects as compared are given in Table 4 . to the approach with cerebellum as reference region (Table 3) . Also, with this approach, high squares Scatchard analysis were obtained for the equations representing the For the Scatchard analysis, equilibrium values first 3 min after injection of e l C]raclopride with low for specific binding B and free [llC]raclopride con-SA. centration F were obtained at the point in time In addition to Kd, the three kinetic approaches when dCbldt was O. For the three subjects, this mo- F statistics: p < 0.001
Quantitative approach with enantiomer
Three statistical methods were used to select the most significant model. F statistic , the Akaike information criterion (AIC), and Schwarz criterion (SC). For the F statistic, the null hypothesis was that the two-compartment model more adequately describes radioligand uptake. The p value indicates on what level the null hypothesis was rejected. The AIC and SC give a number for each model.
The lowest number indicates the preferred model. RSS = residual sum of squares. ment occurred 26, 21, and 27 min after the injection of [1 l C]raclopride with high SA and after 16, 18, and 18 min when a low SA was used. The Scatchard curves are presented in Fig. 5 and the Bmax and Kd values are given in Table 4 .
Examination of the compartment Cf
Both a two-compartment and a three-com partment model were fitted to the time-activity curves obtained from the cerebellum. Table 4 summarizes the re sults of the model fits and the outcome of the comparisons tests of the models. In all subjects, at both high and low SA of e'C]raclopride, the three-compartment model with four rate constants gave the best fit. When analyz ing uptake of the inactive enantiomer e IC] FLB472 in the cerebellum, the three-compartment model with four rate constants gave a better fit . For FLB-472 in the putamen, the three-compartment model only gave a better fit in subject C. The k3 and k4 values found in the cerebellum for [IlC]FLB472 were similar to those fo und in the cerebellum after the two specific activities of e 'C]raclopride.
DISCUSSION
For each model applied to PET experiments with radio ligands , a critical evaluation must be made of whether the model represents an adequate descrip tion of the pharmacokinetics and binding character istics of the radioligand .
After intravenous injection, radioligands associ ate to binding sites on plasma proteins . The protein binding in plasma of [IIC]raclopride was 94.0-95 . 7%, corre sponding to a free fraction that ranged from 4.3 to 6.0%. We have previously reported that the steady-state concentration of [1'C]raclopride in brain regions devoid of specific binding is linearly related to the concentration of non-protein-bound radioligand in plasma and not to the total concen tration (Farde et aI. , 1989a) . The question remains: to what extent does protein binding affect the ex traction of [1lC]raclopride from blood to brain? The capillary transit time in brain is about 1 s (Furlow and Bass, 1976) . A half-time of less than 1 s has been reported for the dissociation of substances that bind to plasma albumin (Pardridge, 1981; Hill ier, 1975) . If dissociation is fast compared to capil lary transit time, net transport of radioligand from plasma to brain would result in a continuous disso ciation of ligand from plasma proteins during the 1 s passage of blood through the capillaries. The first pass extraction for ["C]raclopride was 30% fo r the whole brain although only 4% of ["C]raclopride in plasma was free. This finding is consistent with an indeed very rapid dissociation of ["C]raclopride from the plasma proteins. This finding is also in agreement with re sults obtained with other com pounds such as propranolol, where a different tech nique has been used to demonstrate a first-pass ex traction of 65 % (Olesen et aI. , 1973) , despite a free fraction in plasma of only 10--20% (Shand et aI., 1976) .
Fit of the three-compartment model
The three-compartment model was fitted to the uptake curve, Ctiss(t), obtained for the putamen af ter injection of e 'C] raclopride with high SA. The fits were very good in all subjects ( Fig. 4A-C) , sug gesting that the three-compartment model can be used to describe regional uptake and specific bind ing of ["C]raclopride in brain.
(a) Quantitative approach with reference tissue and Scatchard analysis
The radioactivity concentration in the cerebellum was used as an estimate of CIt) both in this kinetic approach and in the Scatchard analysis. The Bmax and Kd values obtained for specific ["C]raclopride binding in the putamen were similar in both ap proaches (Table 3 ) . This similarity is expected theo retically, since the equations for saturation curves at equilibrium conditions can be derived from the three-compartment model with four rate constants (cf. the Methods section) .
(b) Quantitative approach with enantiomer
When k, and k2 were estimated from the experi ments with e 'C]FLB472 and used to calculate Cit) according to Eq. (5), it was possible to obtain rea sonable binding parameters only for subject C (Ta ble 3) . For subjects A and B, the Bmax values were close to O.
The free fractions of [1lC]FLB472 in plasma were higher for [I l C]FLB472 than for [1 l C]raclopride (cf.
the Results section) . The k, values were also higher fo r e'C]FLB472 than fo r [ l 1C] raclopride, indicating that a higher free fraction is reflected in a higher first-pass extraction fraction (Table 4) . Differences in plasma protein binding has been demonstrated for several enantiomeric pairs (Giacomini et aI., 1985; Olanoff et aI., 1984; Thijssen et aI ., 1985) . A difference in plasma protein binding may also indi cate a quantitatively or qualitatively diffe rent bind ing to other proteins, such as those that contribute to nonspecific binding in brain tissue .
(c) Quantitative approach with five parameters
The program was used to find k l and k2 in addi tion to Bmax, kon' and koff' The Bmax values were slightly lower in all subjects than when radioactivity in the cerebellum was used as an estimate of Cr<t)
[approach (a)] . The Bmax values obtained with both approaches were of the same order as those in vitro, where values of about 15 pmol/g has been reported for eH]raclopride binding in postmortem human brain material (Hall et aI ., 1988a) . The rate constants k l and k2 were used to calcu late Cr<t) predicted by the model. The level of Cr<t) closely followed the level of the measured values obtained from the cerebellum (Fig. 4A-C) . In all subjects, it is noteworthy that in the early phase after injection of a tracer dose of e IC]raclopride, the predicted Cr<t) was lower than the measured cerebellar radioactivity (Fig. 4A-C ) . Such regional diffe rences may be explained by variations in tissue composition. It is also expected theoretically that Cr<t) should be lower in the early phase after ligand injection if specific binding sites are available than if they are not . Remembering that dCtis /dt = dC;dt + dCb/dt, such difference can be understood by inspection of Eq. (5):
In the early phase after ligand injection, when there is a rapid association of ligand , dCb/dt is large and Cr<t) becomes lower. In the late phase , when there is a net dissociation of binding, dCb/dt is negative and Cr<t) higher than if there were no receptor ligand complexes in the region.
Examination of the compartment Cr
The simple form of the model equations given here implies a uniform distribution of ligand in the tissue volume. The compartment Cr, however, rep resents several physical compartments such as the intracellular and extracellular water space . Consid ering the high lipophilicity of all radioligands used for the study of brain receptors, distribution to fat is also a possibility. Cr also represents several bio-chemical compartments such as spe cific ligand binding to non-D2-dopamine receptors, nonspecific ligand binding to cell membranes, or ligand bound to proteins in the extracellular fluid . The actual con centration of free radioligand in the synaptic cleft of the dopaminergic nerve terminals is consequently not known.
Assuming that there is a rapid equilibration be tween free and nonspecifically bound radioligand in brain after ligand injection, Mintun et aI . (1984) have introduced a constant, the factor 12 in their model equations. 12 represents the fraction of free radioligand molecules in brain tissue . They reported 12 to be 1-2% for [l sF]spiperone in the cerebellum of baboons (Perlmutter et aI ., 1986) . Logan et aI. (1987) determined 12 for eSF]spiperone in baboons using the expression k l lk2 = I l if2' where II repre sents the non-protein-bound fraction in plasma. As suming II to be 10%, they reported 12 to be on the order of I %. In the present study, measured II for [llC]raclopride was about 4%. Using the values in the putamen for k l and k2 (Table 2) , the calculated values for 12 are about 10%. Accordingly, only a minor fraction of the [I1C]raclopride molecules in brain tissue is free and available to interact with the receptors. AI 2 value of about 10% would not affect Such values are close to the Kd values of 2 nM re ported for eH]raclopride binding to human brain homogenates in vitro (Hall et aI., 1988a) .
The kinetic approaches allowed separate determi nations of the rate constants kon and koff (Table 3) . The value of 0. 10 found for the unimolecular disso ciation rate constant koff in approach (c) was in ex cellent agreement with the koff values obtained in vitro at 37°C for eH]raclopride binding to rat brain striatal membranes (Hall et aI ., 1988b) . The values of about 0.01 for the bimolecular association rate constant kon were much lower than the values of 0.05 found in vitro at 37°C . This difference is most likely related to the fact that only a minor fraction of [I IC]raclopride in brain is free to associate to the receptors (see above).
The comparison of the two-and three-compart ment models in the cerebellum , a region devoid of specific D2-dopamine receptor binding, was under taken to further examine [ llC]raclopride and
[llC]FLB472 in the compartment Cf' The three compartment model gave a significantly better fit than the two-compartment model (Table 4 ) . This finding indicates that the compartment Cf in the cer-ebellum can be subdivided in at least two compart ments in whom uptake is described by the rate con stants presented in Table 4 . It should be pointed out that the region cerebellum is anatomically hetero geneous and consists of both white and gray matter. A factor that could account for the "a dditional compartment" is metabolites crossing the blood brain barrier. However, Kohler et al . (1985) found that after i.v. injection of eH]raclopride into rats, more than 90% of the radioactivity in the brain after 45 min represented the unchanged compound. The metabolites of raclopride are at present identified and characterized in a study with e4C]raclopride on healthy male subjects. Logan et al . (1987) examined the uptake of eSF]spiperone in the cerebellum of baboons and re ported a significantly better fit when a three compartment model with a rate constant k3 was used (k4 = 0) than with a two-compartment model .
They concluded that the activity represented by this third compartment is not related to specific receptor binding since that was blocked by the Drdopamine receptor antagonist ( + )-butaclamol. In the present study, the k3 values found in the cerebellum after injection of e IC]raclopride with a low SA were not lower than those after a high SA. These almost identical k3 values indicate that the values do not describe binding to sites that are saturable within the dose range studied (1-800 fLg) . When e IC]_ FLB472 was used, the k3 and k4 values obtained in the cerebellum were similar to those obtained with e IC]raclopride in the cerebellum , indicating that the compartment described by those rate constants does not represent stereoselective binding sites to receptors .
The evaluation of the validity of both the kinetic and the equilibrium approach is based on a detailed knowledge about the components that in vivo con stitute the compartment designated "f ree radioli gand in brain tissue," Cr. For the radioligands used in in vivo experiments with PET, such knowledge is, so far , limited. If there is a rapid equilibration between the free fraction of C[ and other compart ments included in C[, it is reasonable to assume that the free fraction is not time dependent . To correct for the free fraction, the factor 12 can accordingly be introduced in the model equations (Mintun et aI ., 1984) . However, the identified low rate constants k3 and k4 in regions with no specific e IC]raclopride binding imply that the equilibration is not rapid and that 12 ' the free fraction of Cit), may be time de pendent. In the present analysis, 12 was therefore set to l.
In the kinetic approaches (a) and (c) , the equa tions representing the first minutes after injection of J Cereb Blood Flow Metab, Vol. 9, No.5, 1989 [IIC]raclopride with low SA gave comparatively high residual squares. The measured values were higher than those predicted by the model. When [11C]raclopride with a low SA was used, about 1 mg of [ llC]raclopride dissolved in 2 ml of saline was injected as a bolus. Those 2 ml are mixed with only a limited volume of blood before passing the brain. It is possible that the binding capacity of the plasma proteins is limited and that I I ' the free fraction of e IC]raclopride in plasma, is higher at that initial moment. Such an effect would result in an in creased first-pass extraction of [ llC]raclopride with low SA and higher initial values for C��s T(t) than those predicted by the model. This effect may also be a reason to the earlier equilibrium (dCbldt = 0) after low SA than after high SA.
A kinetic analysis of [ llC]NMSP uptake in the striatum before and after administration of haloper idol has been developed fo r the study of D2dopamine receptor densities in healthy controls and neuroleptic-naive patients with schizophrenia (Wong et aI ., 1986b) . A two-to threefold elevation in densities was reported in the patients. Using e IC]raclopride and the equilibrium approach , no el evation in D2-dopamine receptor densities was found in neuroleptic-naive schizophrenic patients as compared to healthy controls (Farde et aI ., 1987) . Differences between the kinetic and the equilibrium analysis of ligand binding have been discussed as a reason for these highly discrepant findings (An dreasen et aI ., 1988) . The theoretically expected and, in the present paper, experimentally verified similarity between density values obtained with the kinetic and the equilibrium analysis does not sup port that view.
The present kinetic analyses of [ llC]raclopride binding to central D2-dopamine receptors gave Bmax and Kd values that were similar to those obtained with an equilibrium analysis. The analyses also pro vided separate values for the association and disso ciation rate constants. The findings of the present study strengthen the rationale of using e IC]_ raclopride for quantitative studies of D2-dopamine receptor binding by PET.
